All Stories

  1. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview
  2. Cystic Fibrosis-Related Liver Diseases: New Paradigm for Treatment Based on Pathophysiology
  3. Neural cell adhesion molecule and polysialic acid in ductular reaction: The puzzle is far from completed, but the picture is becoming more clear
  4. Emerging roles of Notch signaling in liver disease
  5. Management of treatment‐naïve chronic hepatitis C genotype 1 patients: a cost‐effectiveness analysis of treatment options
  6. Characterization of animal models for primary sclerosing cholangitis (PSC)
  7. Adhesion to Y-TZP ceramic: Study of silica nanofilm coating on the surface of Y-TZP
  8. Notch signaling and new therapeutic options in liver disease
  9. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study
  10. P1253 ACTIVATION OF PPAR-γ SIGNALING AS A NOVEL TARGET TO LIMIT NF-κB-DEPENDENT INFLAMMATION IN CYSTIC FIBROSIS BILIARY EPITHELIUM
  11. P71 LEUKAEMIA INHIBITORY FACTOR PROTECTS CHOLANGIOCARCINOMA CELLS FROM CYTOTOXICITY VIA A STAT-3-INDEPENDENT, Mcl-1 ACTIVATION
  12. P1215 MANAGEMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 TREATMENT-NAIVE PATIENTS IN AN ERA OF RISING OPPORTUNITIES AND COSTS – A COST-EFFECTIVENESS ANALYSIS OF TREATMENT OPTIONS
  13. Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis
  14. Leukaemia inhibitory factor protects cholangiocarcinoma cells from cytotoxicity via a STAT-3-independent, Mcl-1 activation
  15. Notch signalling beyond liver development: Emerging concepts in liver repair and oncogenesis
  16. Protein kinase a-dependent pSer675 -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis
  17. EASL Recognition Awardee 2013
  18. Healthcare costs associated with hepatocellular carcinoma and the value of care
  19. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: The egg of columbus or another illusion?
  20. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma
  21. Vascular biology of the biliary epithelium
  22. Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice
  23. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study
  24. 137 CXCL1 AND CXCL10 SECRETION BY FIBROCYSTIN-DEFECTIVE CHOLANGIOCYTES RECRUITS PERIBILIARY FIBROCYTES IN CONGENITAL HEPATIC FIBROSIS
  25. Toward a rational management of very early hepatocellular carcinoma
  26. Pathway-based analysis of primary biliary cirrhosis genome-wide association studies
  27. OC-06 Rac1 and Cdc42 activation regulates PDGF-D-mediated CAF recruitment by cancer cells in cholangiocarcinoma
  28. OC-01 CXCL1 and CXCL10 secretion by Fibrocistin-defective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis
  29. F-23 Leukaemia inhibitory factor protects cholangiocytes from cytotoxicity in cholangiocarcinoma
  30. The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?
  31. Notch Signaling in Hepatocellular Carcinoma: Guilty in Association!
  32. PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases
  33. O5 GUT–LIVER AXIS AND ALTERED TLR INNATE IMMUNITY IN THE PATHOGENESIS OF CYSTIC FIBROSIS LIVER DISEASE
  34. Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib
  35. PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases
  36. 8 Disorders of bile duct development
  37. Development of the bile ducts: Essentials for the clinical hepatologist
  38. Polycystic liver diseases
  39. 269 SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM
  40. 31 MONOCYTE/MACROPHAGE PERIBILIARY RECRUITMENT BY PKHD1-DEFECTIVE CHOLANGIOCYTES INDUCES EXPRESSION OF αvβ6 INTEGRIN ON BILIARY CYSTS VIA TGF-β1 AND TNF-α IN CONGENITAL HEPATIC FIBROSIS
  41. Altered store operated calcium entry increases cyclic 3′,5′-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes: [RETRACTED]
  42. OC.08.5 SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM
  43. OC.05.1 MONOCYTE/MACROPHAGE PERIBILIARY RECRUITMENT BY PKHD1-DEFECTIVE CHOLANGIOCYTES INDUCES EXPRESSION OF AVB6 INTEGRIN ON BILIARY CYSTS VIA TGFB1 AND TNFA IN CONGENITAL HEPATIC FIBROSIS
  44. OC-2 Selective reduction in S100A4 nuclear expression by low-dose paclitaxel halts invasiveness of human cholangiocarcinoma cells through a Rac1-independent, Rho-A/Cdc42-dependent mechanism
  45. OC-6 Monocyte/macrophage peribiliary recruitment by Pkhd1-defective cholangiocytes induces expression of αvβ6 integrin on biliary cysts via TGFβ1 and TNFα in congenital hepatic fibrosis
  46. “The city of Hepar”: Rituals, gastronomy, and politics at the origins of the modern names for the liver
  47. Loss of CFTR Affects Biliary Epithelium Innate Immunity and Causes TLR4–NF-κB—Mediated Inflammatory Response in Mice
  48. co activation of FXR and TGR5 ameliortaes cholangiopathy via FXR
  49. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization
  50. Faculty Opinions recommendation of Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells.
  51. Systemic Therapy in Hepatocellular Carcinoma
  52. P.1.63: ACTIVATION OF STORE-OPERATED CAMP SIGNALING IS RESPONSIBLE FOR ERK 1/2 PHOSPHORYLATION IN POLYCYSTIN-2/TRPP2 DEFECTIVE CHOLANGIOCYTES
  53. OC.10.4: PKA-DEPENDENT P-SER-675β-CATENIN PHOSPHORYLATION INCREASES CHOLANGIOCYTE MOTILITY IN A MOUSE MODEL OF FIBROPOLYCYSTIC LIVER DISEASES
  54. 50 PKA-DEPENDENT P-SER-675β-CATENIN PHOSPHORYLATION INCREASES CHOLANGIOCYTE MOTILITY IN PKHDDEL4/DEL4 MICE, A MODEL OF FIBROPOLYCYSTIC LIVER DISEASES CAUSED BY DEFECTIVE FIBROCYSTIN FUNCTION
  55. 701 INAPPROPRIATE STORE-OPERATED CYCLIC-AMP PRODUCTION LINKS ALTERED ENDOPLASMIC RETICULUM (ER) CA2+ HOMEOSTASIS TO ERK/VEGF SIGNALING IN TRPP2-DEFECTIVE CHOLANGIOCYTES IN A MOUSE MODEL OF POLYCYSTIC LIVER DISEASE
  56. 518 UNFAVORABLE IMPACT OF HCV INFECTION ON TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH COMPENSATED LIVER DISEASE: INSIGHTS FROM THE LIVER MATCH COHORT STUDY
  57. Epithelial-Mesenchymal Interactions in Biliary Diseases
  58. Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor–recipient matching
  59. OC-29 The allocation policy of liver grafts from HBcAb positive donors needs to be improved: Evidence from the Liver-Match cohort study
  60. Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the “Cholangiocarcinoma” committee of the Italian Association for the Study of Liver disease
  61. Vergangenheitsaufarbeitung im postautoritären Argentinien
  62. Faculty Opinions recommendation of Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease.
  63. Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C
  64. OC3 Platelet-Derived Growth Factor (PDGF) signalling mediates cancer-associated fibroblasts (CAFs) recruitment in cholangiocarcinoma
  65. OC8 Defective progenitor cells activation and biliary tubule formation in liver conditional RBP-Jk-knock out mice exposed to cholestatic injuries reveals a key role for Notch signaling in liver repair
  66. P3 Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C
  67. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
  68. Foxa1 and Foxa2 regulate bile duct development in mice
  69. M1010 Improved One-Year Graft Survival in Liver Transplant Recipients Treated With Mychophenolate Mofetil: Results of the Liver-Match Prospective Cohort Study
  70. Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-C
  71. 27 USE OF STEROIDS AFTER LIVER TRANSPLANTATION IS ASSOCIATED WITH LOWER RISK OF EARLY GRAFT FAILURE (EGF): INSIGHTS FROM THE LIVER MATCH PROSPECTIVE STUDY
  72. 74 CANCER-ASSOCIATED FIBROBLASTS RECRUITMENT IS MEDIATED BY PLATELET-DERIVED GROWTH FACTOR (PDGF) SIGNALING IN CHOLANGIOCARCINOMA
  73. 45 LACK OF CFTR AFFECTS THE INNATE IMMUNITY OF THE BILIARY EPITHELIUM AND DETERMINES A TLR4/NF-κB-MEDIATED INFLAMMATORY RESPONSE
  74. Faculty of 1000 evaluation for Foxa1 and Foxa2 regulate bile duct development in mice.
  75. OC.05.1 CANCER-ASSOCIATED FIBROBLASTS RECRUITMENT IS MEDIATED BY PLATELET-DERIVED GROWTH FACTOR (PDGF) SIGNALING IN CHOLANGIOCARCINOMA
  76. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria
  77. 24 EARLY USE OF MYCHOPHENOLATE MOFETIL IS A MAJOR DETERMINANT OF ONE YEAR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: RESULTS FROM THE LIVER MATCH PROSPECTIVE COHORT STUDY
  78. 32 CANCER-ASSOCIATED FIBROBLAST (CAF) RECRUITMENT IS MEDIATED BY PARACRINE PLATELET-DERIVED GROWTH FACTOR (PDGF) SIGNALLING IN CHOLANGIOCARCINOMA
  79. T.N.1 LACK OF CFTR AFFECTS THE INNATE IMMUNITY OF THE BILIARY EPITHELIUM AND DETERMINES A TLR4/NF-κB-MEDIATED INFLAMMATORY RESPONSE
  80. F.N.3 PROGENITOR CELL ACTIVATION AND LIVER REPAIR IS ALTERED IN NOTCH2- AND RBP-Jκ-DEFECTIVE MICE EXPOSED TO CHOLESTATIC INJURIES
  81. Cholangiocyte Biology as Relevant to Cystic Liver Diseases
  82. ERK1/2-Dependent Vascular Endothelial Growth Factor Signaling Sustains Cyst Growth in Polycystin-2 Defective Mice
  83. Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice
  84. Faculty Opinions recommendation of Notch signaling controls liver development by regulating biliary differentiation.
  85. 295 LIVER FIBROSIS IS INDUCED BY INSULIN RESISTANCE BY ENHANCING THE DUCTULAR REACTION THAT UNDERGO EPITHELIAL-MESENCHYMAL TRANSITION IN CHRONIC HEPATITIS C
  86. 456 HCC PERSISTENCE OR RECURRENCE AFTER BRIDGING THERAPY HELPS PREDICT TRANSPLANT LIST DROPOUT AND GENERATE A MORE EQUITABLE EXCEPTION POLICY
  87. 72 RAPAMYCIN INHIBITS CYST GROWTH, IGF-1-MEDIATED VEGF SECRETION AND CELL PROLIFERATION IN POLYCYSTIN-2 DEFECTIVE MICE, A MODEL FOR POLYCYSTIC LIVER DISEASE (PLD) ASSOCIATED TO ADULT-DOMINANT-POLYCYSTIC-KIDNEY-DISEASE (ADPKD)
  88. Diferentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation
  89. LIVER FIBROSIS IS INDUCED BY INSULIN RESISTANCE BY ENHANCING THE DUCTULAR REACTION THAT UNDERGO EPITHELIAL-MESENCHYMAL TRANSITION IN CHRONIC HEPATITIS C
  90. HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy
  91. Nuclear expression of S100A4, an early marker of epithelial–mesenchymal transition (EMT), predicts a more aggressive behaviour in cholangiocarcinoma
  92. Rapamycin inhibits cyst growth, IGF-1-mediated VEGF secretion and cell proliferation in polycystin-2 defective mice
  93. Liver fibrosis is induced by insulin resistance by enhancing the ductular reaction that undergo epithelial–mesenchymal transition in chronic hepatitis C
  94. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice
  95. Side-chain modification as critical determinant of the therapeutic properties of 24-norursodeoxycholic acid in Mdr2 (Abcb4) knockout mice
  96. Ductular reaction is driven by insulin resistance and undergoes epithelial–mesenchymal transition in chronic hepatitis C
  97. Incidence and Management of Colorectal Cancer in Liver Transplant Recipients
  98. Type I Autoimmune Hepatitis Presenting With Acute Liver Failure in the Setting of Wild Mushroom Ingestion
  99. ROLE OF CFTR IN BILE SECRETION
  100. Faculty Opinions recommendation of The hepatic stem cell niche: identification by label-retaining cell assay.
  101. Functional Anatomy of Normal Bile Ducts
  102. Evidence for epithelial–mesenchymal transition in the biliary epithelium of human cholangiocarcinoma
  103. Prognostic Prediction in Hepatocellular Carcinoma
  104. PA.191 COMBINED ANTIVIRAL THERAPY(PEG-IFN +RIBAVIRINE) IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION. AN ITALIAN EXPERIENCE OF TWO TRANSPLANT CENTRES
  105. Faculty Opinions recommendation of Identification of adult hepatic progenitor cells capable of repopulating injured rat liver.
  106. Morphological and Functional Features of Hepatic Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease
  107. Faculty Opinions recommendation of Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
  108. 325 EVIDENCE FOR BILIARY EPITHELIAL TO MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA
  109. Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development
  110. Ursodeoxycholic Acid Stimulates Cholangiocyte Fluid Secretion in Mice via CFTR-Dependent ATP Secretion
  111. Combined sequential bilateral single lung – liver transplantation for cystic fibrosis
  112. Prognostic factors affecting 1-year hepatocellular carcinoma (HCC) progression in liver transplantation candidates
  113. Combined Double Lung–Liver Transplantation for Cystic Fibrosis Without Cardio‐Pulmonary By‐Pass
  114. Hepatic Venous Pressure Gradient (HVPG), Serum Sodium (SNa), and Model of End-stage Liver Disease Score (MELD)
  115. Analysis of Liver Repair Mechanisms in Alagille Syndrome and Biliary Atresia Reveals a Role for Notch Signaling
  116. Faculty Opinions recommendation of Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
  117. Inheritance of hyperbilirubinemia: Evidence for a major autosomal recessive gene
  118. [185] CENTRILOBULAR NECRO-INFLAMMATORY CHANGES IN HCV-NEGATIVE LIVER TRANSPLANT RECIPIENTS RESPOND TO TREATMENT WITH STEROIDS AND MYCOPHENOLATE MOFETIL
  119. [272] COMPARISON OF C.L.I.P., T.N.M. AND B.C.L.C. STAGING SYSTEMS FOR HEPATOCELLULAR CARCINOMA (HCC) IN A COHORT OF PROSPECTIVELY FOLLOWED HCC PATIENTS
  120. [105] ARTERIAL AND PERIBILIARY VASCULOGENESIS DURING LIVER DEVELOPMENT IS MODULATED BY ANGIOGENIC GROWTH FACTORS EXPRESSED BY DUCTAL PLATE CELLS AND HEPATOBLASTS
  121. Arterial and peribiliary vasculogenesis during liver development is modulated by angiogenic growth factors expressed by ductal plate cells and hepatoblasts
  122. Prognosis of hepatocellular carcinoma: Comparison of CLIP, TNM, and BCLC in a cohort of patients followed prospectively at a single referral center
  123. Centrilobular necro-infiammatory changes in liver transplant recipients respond to treatment with steroids and mycophenolate mofetil
  124. Treatment With Pegylated Interferon and Ribavirin for Hepatitis C Virus-associated Severe Cryoglobulinemia in a Liver/Kidney Transplant Recipient
  125. Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry
  126. Faculty Opinions recommendation of Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease.
  127. Extended right split liver graft for primary transplantation in children and adults*
  128. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases
  129. Estrogens and IGF1 promote the proliferation of hepatic cyst epithelium in autosomal dominant polycystic kidney disease (ADPKD)
  130. Altered jagged-1/notch signalling influences liver repair mechanisms in alagille syndrome
  131. 96 Estrogens and IGF1 promote the proliferation of hepatic cyst epithelium in autosomal dominant polycystic kidney disease (ADPKD)
  132. Faculty Opinions recommendation of Activation of CFTR by ASBT-mediated bile salt absorption.
  133. Faculty Opinions recommendation of Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells.
  134. Faculty Opinions recommendation of Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger.
  135. Glibenclamide Stimulates Fluid Secretion in Rodent Cholangiocytes Through a Cystic Fibrosis Transmembrane Conductance Regulator-Independent Mechanism
  136. Practice of adult liver transplantation in Italy
  137. Pathophysiology of Cholangiopathies
  138. Use of Extended Right Grafts From In Situ Split Livers in Adult Liver Transplantation: A Comparison With Whole-Liver Transplants
  139. The cholangiopathies: Disorders of biliary epithelia
  140. SPLIT LIVER TRANSPLANTATION WITH PEDIATRIC DONORS: RESULTS OF A MULTICENTRIC EXPERIENCE.
  141. USE OF EXTENDED RIGHT GRAFTS FROM IN-SITU SPLIT LIVER FOR TRASPLANTATION IN ADULTS: A COMPARISON WITH WHOLE LIVER TRANSPLANTS
  142. Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats
  143. Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests
  144. 100 Peginterferon alfa-2A (40KD) with or without ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Preliminary report of a randomized study
  145. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C1 1The authors thank Wanda Delogu and Nadia Navari for skillful technical help, Dr. Roberto G. Romanelli for help in collecting liver biopsy specimens, and Dr. Mari...
  146. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population
  147. Detection of recipient's cells in liver graft using antibodies to mismatched class I MHC antigens
  148. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes
  149. 30 Liver transplantation for cystic fibrosis-related liver disease
  150. 24 Expression of angiogenic factors/receptors system in autosomal dominant polycystic liver disease (ADPLD)
  151. 3 Detection of recipients cells in liver graft using antibodies to mismatched MHC class I antigens
  152. 1103 Expression and regulation of adenylyl cyclase isoforms (ACS) in rat cholangiocytes; effects of lipopolysaccaride (LPS) and α-napthylisothiocyanate (ANIT) treatment
  153. Experience with the use of basiliximab in liver transplantation—use in pediatric and adult recipients in combination with cyclosporine or tacrolimus
  154. Defective regulation of cholangiocyte Cl− /HCO− 3 and Na+ /H+ exchanger activities in primary biliary cirrhosis
  155. 4 P Glibenclamide induces ductal secretion stimulating vesicular transport in cholangiocytes
  156. 2 P Non-cardiac chest pain (NCCP) in patients with non-erosive reflux disease (NERD) and erosive disease
  157. Glibenclamide induces ductal secretion stimulating vesicular transport in cholangiocytes
  158. Low ferritin levels and body mass index are independent predictors of persitently normal alt levels in HCV RNA positive subjects
  159. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb‐threatening diabetic foot infection
  160. Proinflammatory Cytokines Inhibit Secretion in Rat Bile Duct Epithelium
  161. Ductular morphogenesis and functional polarization of normal human biliary epithelial cells in three-dimensional culture
  162. HLA-DRB1 and tumor necrosis factor a but not cystic fibrosis transmembrane conductance regulator genes contribute to the genetic susceptibility of primary sclerosing cholangitis
  163. Minimal change cholangiopathy (MCC)
  164. Randomized Prospective Controlled Trial of Recombinant Granulocyte Colony-Stimulating Factor as Adjunctive Therapy for Limb-Threatening Diabetic Foot Infection
  165. Correction
  166. The contribution of MHC region genes and the mutations of the CFTR gene in the genetic predisposition to primary sclerosing cholangitis (PSC)
  167. Characterization and Isolation of Ductular Cells Coexpressing Neural Cell Adhesion Molecule and Bcl-2 from Primary Cholangiopathies and Ductal Plate Malformations
  168. The contribution of MHC region genes in the genetic predisposition to primary sclerosing cholangitis (PSC)
  169. Pathophysiology of the intrahepatic biliary epithelium
  170. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications
  171. Correction of defective CFTR function in bile ductular cells from a patient with cystic fibrosis
  172. The monoethylglycinexylidide test for grading of liver cirrhosis
  173. Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines
  174. Biliary tract physiology
  175. Impaired Cl−/HCO3− exchanger activity, associated with defective Cl− conductance, can be restored by purinergic stimulation in a cystic fibrosis pancreatic duct cell line (CFPAC-1)
  176. Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery
  177. Liver and Biliary Problems in Cystic Fibrosis
  178. Proinflammatory cytokines stimulate nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) gene expression in rat cholangiocytes
  179. New insights into cholangiocyte physiology
  180. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients
  181. Na+-dependent and -independent Cl?/HCO3? exchange mediate cellular HCO3? transport in cultured human intrahepatic bile duct cells
  182. Regulation of intracellular pH in the hepatocyte
  183. Intracellular pH regulation in hep G2 cells: Effects of epidermal growth factor, transforming growth factor-α, and insulinlike growth factor-II on Na+/H+ exchange activity
  184. Intracellular pH regulation in hep G2 cells: Effects of epidermal growth factor, transforming growth factor-?, and insulinlike growth factor-II on Na+/H+ exchange activity*1, *2
  185. Haemophilia treatment centres: old and new challenges
  186. Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes.
  187. Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line
  188. Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line,
  189. A study on the hyperinsulinism of late pregnancy
  190. Intracellular pH regulation in isolated rat bile duct epithelial cells.
  191. Effect of Silibinin on biliary lipid composition experimental and clinical study
  192. The use of isolated rat hepatocyte couplets, microscopic optical planimetry and quantitative microfluorimetry in hepatobiliary physiology
  193. Effect of age on single- and multiple-dose pharmacokinetics of erythromycin
  194. Intracellular pHi regulation in isolated rat bile ductular cells
  195. Mechanism of Cyclosporin A- and Phalloidin-induced Liver Injury: Experimental Studies on Hepatic Bilirubin Transport
  196. Quantitative assessment of canalicular bile formation in isolated hepatocyte couplets using microscopic optical planimetry.
  197. From meetings
  198. Epidemiology of Unconjugated Hyperbilirubinemia: Revisited
  199. Clinical Significance of Serum Bilirubins: Recent Advances
  200. Bile Acid Treatment of Cholesterol Gallstones: A Reappraisal
  201. Antipyrine Clearance: Evaluation of Simplified Methods in Chronic Liver Diseases
  202. Biliary Lipid Composition after Endoscopic Sphincterotomy in Postcholecystectomy Patients: Effect of Short-Term Ursodeoxycholic Acid Administration
  203. The Effect of Drugs on Bile Flow and Composition
  204. Effect of silybin on biliary lipid composition in rats
  205. 243. Testosterone (T),estrone (E1),17β estradiol (E1) and androstenedione (A) in male subejects affected by porphyria cutanea tarda